Project Grant R01AI175177
Award Date
7/1/24
Completion Date
5/31/29
Dollars Obligated
$867K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Brown University (E3FDXZ6TBHW3)
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Providence, RI 02912, USA
Similar Awards
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $265,650 to support research on the evolutionary dynamics of the opportunistic fungal pathogen Candida glabrata in the gastrointestinal tract. The study aims to elucidate how antifungal drug treatment and immune dysfunction influence the adaptation and evolution of gut-colonizing C. glabrata, which can lead to...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $857,215 in funding to Hackensack University Medical Center (HUMC) to conduct research on how the fungal pathogen Candida albicans adapts and causes infections in different parts of the human body. The key objectives are to identify and characterize how the C. albicans GCN5 protein, which regulates gene...
This federal Project Grant award, with a total funding amount of $233,670.00, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The primary objective of this award is to investigate the genetic mechanisms that govern skin colonization by the emerging fungal pathogen Candida auris, which poses a critical public health concern due to its high mortality rate and ability to spread easily...
This federal Project Grant award, totaling $494,696.00, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research at the University of Texas Health Science Center at San Antonio (UTHSCSA) to investigate translational control mechanisms that enable the fungal pathogen Candida albicans to respond to host environmental stresses and transition between yeast and filamentous...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) is funding research to investigate the regulation of chloride-driven fluid secretion in the gut and how the fungus Candida albicans subverts this host defense mechanism during invasive candidiasis. The $318,554 award to Valparaiso University will support three specific aims: 1) determining if the...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), is funding research at Prokaryotics Incorporated to develop novel antifungal inhibitors targeting the glycosylphosphatidylinositol (GPI) biosynthesis pathway. The $170,000 award, running from February 1, 2025 to January 31, 2027, supports structural elucidation of the C. albicans GPI ethanolamine phosphate transferase enzyme...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $216,264 to the University of Colorado-Denver to conduct research on the interactions between Group B Streptococcus (GBS) and the fungus Candida albicans (CA) within the gastrointestinal and reproductive tracts. The research aims to characterize how the presence of CA impacts the virulence and colonization of...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $152,216 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to the University of Pittsburgh to study anti-fungal immune responses in the female reproductive tract. The research aims to determine the cellular and molecular basis for how type 3 cytokine signaling orchestrates immune control of vulvovaginal candidiasis (VVC), a prevalent and burdensome fungal infection that affects over 75% of women....
This $134,800 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under CFDA 93.855 Allergy and Infectious Diseases Research will support research to study the role of multi-drug resistant Candida auris Hyr1/Iff-like proteins in virulence and their potential as vaccine targets. The principal investigator, Dr. Shakti Singh, an accomplished immunologist at The Lundquist Institute, will leverage his expertise to fill gaps in his fungal research knowledge...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to advance the development of natural phenolic compounds, specifically caffeic acid phenethyl ester (CAPE) and ellagic acid (EA), for the management of oral candidiasis. The $416,396 award, running from August 2024 to July 2029, will fund three key objectives: 1) optimizing hydrogels loaded with EA and/or CAPE to...